Cart
sales@molnova.com
Clofibric acid
CAS No. 882-09-7
Clofibric acid( NSC 1149 )
Catalog No. M16397 CAS No. 882-09-7
Clofibric acid is a PPARα agonist and hypolipidemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClofibric acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionClofibric acid is a PPARα agonist and hypolipidemic agent.
-
DescriptionClofibric acid is a PPARα agonist and hypolipidemic agent.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 1149
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number882-09-7
-
Formula Weight214.65
-
Molecular FormulaC10H11ClO3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 43 mg/mL (200.32 mM); DMSO: 43 mg/mL (200.32 mM)
-
SMILESCC(C)(OC1=CC=C(Cl)C=C1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richert L, et al. Toxicol Appl Pharmacol, 2003, 191(2), 130-146.
molnova catalog
related products
-
MK-0533
MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
-
GQ-16
GQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
-
KD-3010
KD-3010 (Kalypsys) is an orally active potent and selective PPARδ agonist for the study of liver injury.
